Trial intelligence / Profile preview

Oral vs Intravenous PPI in Peptic Ulcer Bleeding

NCT01123031Phase 4Withdrawn

Sponsor
Changhua Christian Hospital
Start
Apr 2010
Primary completion
Mar 2012
Modality
Small Molecules
01

Overview

A Phase 4 trial of lansoprazole in peptic ulcer disease (PUD), sponsored by Changhua Christian Hospital. Planned start Apr 2010; status: withdrawn.

02

Drugs

lansoprazole
03

Conditions

peptic ulcer disease (PUD)

Beyond the preview

Go deeper on NCT01123031.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01123031.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call